These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Cutaneous alternariosis: cytohistological findings in a case diagnosed by fine-needle aspiration biopsy. Ortiz J; Abad M; Bullón A; García I Diagn Cytopathol; 2004 Feb; 30(2):103-4. PubMed ID: 14755760 [No Abstract] [Full Text] [Related]
7. Current drug therapy of systemic mycoses: a review. Yonga G East Afr Med J; 1995 Jun; 72(6):394-8. PubMed ID: 7498014 [TBL] [Abstract][Full Text] [Related]
8. Pediatric fungal infections from head to toe: what's new? Rosenthal JR Curr Opin Pediatr; 1994 Aug; 6(4):435-41. PubMed ID: 7951665 [TBL] [Abstract][Full Text] [Related]
10. Role of oral antifungal agents for the treatment of superficial fungal infections in immunocompromised patients. Millikan LE Cutis; 2001 Jul; 68(1 Suppl):6-14. PubMed ID: 11499333 [TBL] [Abstract][Full Text] [Related]
11. Overview of the treatment of disseminated fungal infections. Hay RJ J Antimicrob Chemother; 1991 Oct; 28 Suppl B():17-25. PubMed ID: 1778889 [TBL] [Abstract][Full Text] [Related]
12. Host immune reactivity and antifungal chemotherapy: the power of being together. Romani L J Chemother; 2001 Aug; 13(4):347-53. PubMed ID: 11589476 [TBL] [Abstract][Full Text] [Related]
13. Prevention of fungal infections in the immunocompromised host. Mahfouz T; Anaissie E Curr Opin Investig Drugs; 2003 Aug; 4(8):974-90. PubMed ID: 14508882 [TBL] [Abstract][Full Text] [Related]
14. Fungal infections with a particular focus on the compromised host. Louria DB; Sen P Del Med J; 1982 Jan; 54(1):11-9. PubMed ID: 7200040 [No Abstract] [Full Text] [Related]
15. Subcutaneous phaeohypomycosis caused by Scytalidium dimidiatum in the foot of an immunosuppressed host. Rockett MS; Gentile SC; Zygmunt KH; Gudas CJ J Foot Ankle Surg; 1996; 35(4):350-4. PubMed ID: 8872760 [TBL] [Abstract][Full Text] [Related]
16. [Effect of new antifungals on the etiology of invasive fungal infections: emergence, resistance and breakthrough infection]. Salavert M; Jarque I Rev Esp Quimioter; 2006 Mar; 19(1):11-3. PubMed ID: 16688286 [No Abstract] [Full Text] [Related]
17. Prevention and prophylaxis of invasive fungal sinusitis in the immunocompromised patient. Malani PN; Kauffman CA Otolaryngol Clin North Am; 2000 Apr; 33(2):301-12. PubMed ID: 10736405 [TBL] [Abstract][Full Text] [Related]
18. Tinea incognito: an update on Majocchi granuloma. Elgart ML Dermatol Clin; 1996 Jan; 14(1):51-55. PubMed ID: 8821157 [TBL] [Abstract][Full Text] [Related]
19. Management of immunocompromised patients with evidence of an invasive mycosis. Walsh TJ Hematol Oncol Clin North Am; 1993 Oct; 7(5):1003-26. PubMed ID: 8226563 [TBL] [Abstract][Full Text] [Related]